Ethical psychedelic facilitation

The manuals converge on ethical psychedelic facilitation as a matter of restraint, professional accountability, and attention to context. Across the extracts, the sources recommend prioritising participant or patient welfare, working within professional ethical standards, and treating psychedelic interventions as something to be used carefully rather than indiscriminately. Several manuals also frame ethical practice as tied to safety, with careful monitoring, appropriate indication, and respect for the early or experimental nature of the evidence base. They also agree that facilitation is not ethically neutral when it is detached from a lawful or clinically justified setting. The ketamine and ibogaine sources explicitly link ethical practice to legal and regulatory boundaries, while the 5-MeO-DMT extract emphasises formal diagnosis and treatment resistance as part of appropriate use. The psilocybin therapy manual adds that ethical delivery is connected to using a structured, evidence-based psychotherapy model rather than an ad hoc approach. The main differences are in emphasis and context. Some manuals focus on legal status and jurisdictional restrictions, especially ketamine and ibogaine, while others focus more on therapist stance and conduct, such as placing participant welfare above personal, ideological, religious, or spiritual convictions.